Biomineralogiczne zjawiska (kalcyfikacji) tętnic

• Autorzy: Pawlikowski M.

Warianty tytułu

EN

Biomineralogical phenomenon (calcification) of arteries

• Języki publikacji: PL

Abstrakty

PL

Przedstawiono teorię biomineralizacji tętnic człowieka. Omówiono przyczyny powstawania i rodzaje centrów krystalizacji w tętnicach. Zaprezentowano wybrane rodzaje mineralizacji tętnic.

EN

Biomineralization of tissues includes both mineralization processes that are necessary for the functioning of the organism and those that are harmful for it. This article discusses both types of mineralization, with particular focuson the occurrence of the so-called crystallization centers, i.e. places where the mineralization begins. Primary and secondary crystallization centers are distinguished. Characteristics of developing biomineralization and its consequences are discussed.

Słowa kluczowe

PL

biomineralizacja; tętnice

EN

biomineralization; arteries

• Wydawca: nakł. Maciej Pawlikowski
• Czasopismo: Auxiliary Sciences in Archaeology, Preservation of Relics and Environmental Engineering
• Rocznik: 2018
• Tom: nr 25
• Strony: 35--50
• Opis fizyczny: Bibliogr. 61 poz., rys., zdj.

Twórcy

autor

Pawlikowski M.

• AGH - Univ. of Science and Technology, Dept. Mineralogy, Petrography and Geochemistry,30-059 Cracow, al. Mickiewicza 30. Poland

Bibliografia

• 1. Abedin M., Lim J., Tang T.B., Park D., Demer L.L., Tintut Y.. 2006 N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor-gamma pathways. Circ. Res., 98: 727–729.
• 2. Allison M.A., Criqui M.H., Wright C.M., 2004 Patterns and risk factors for systemic calcified atherosclerosis. Arterioscl. Thromb. Vasc. Biol., 24: 331–336.
• 3. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD2005 Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J. Am. Coll. Cardiol., 46(1):158-65.
• 4. Bas A., Lopez I., Perez J., Rodriguez M., Aguilera-Tejero E., 2006 Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. J. Bone. Miner. Res., 21: 484–490.
• 5. Bostrom K., Watson K.E., Horn S., Wortham C., Herman I.M., Demer L.L, 1993; Bone morphogenetic protein expression in human atherosclerotic lesions. J. Clin. Invest., 91: 1800–1809.
• 6. Callaway M.P., Richards P., Goddard P., Rees M., 1997 The incidence of coronary artery calcification on standard thoracic CT scans. Br. J. Radiol., 834 :572-574.
• 7. Campbell G.R., Campbell J.H., 2000 Vascular smooth muscle and arterial calcification. Z. Kardiol., 89 (suppl 2): 54–62.
• 8. Canfield A.E., Sutton A.B., Hoyland J.A., Schor A.M., 1996 Association of thrombospondin-1 with osteogenic differentiation of retinal pericytes in vitro. J. Cell Sci., 109 (pt 2): 343–353.
• 9. Cowell S.J., Newby D.E., Prescott R.J., Bloomfield P., Reid J., Northridge D.B., Boon N.A., 2005; A randomized trial of intensive lipidlowering therapy in calcific aortic stenosis. N. Engl. J. Med., 352: 2389– 2397.
• 10. El-Abbadi M., Giachelli C.M., 2007 Mechanisms of vascular calcification. Adv. Chronic. Kidney Dis., 14 :54–66.
• 11. Huang H., Virmani R., Younis H., Burke A.P., Kamm R.D., Lee R.T., 2001 The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation., 103: 1051–1056.
• 12. Iribarren C., Sidney S., Sternfeld B., Browner W.S., 2000 Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA., 283(21):2810-5
• 13. Jono S., McKee M.D., Murry C.E., Shioi A., Nishizawa Y., Mori K., Morii H., Giachelli C.M., 2000 Phosphate regulation of vascular smooth muscle cell calcification. Circ. Res., 87: E10–E17.
• 14. Keelan P.C., Bielak L.F., Ashai K., Jamjoum L.S., Denktas A.E., Rumberger J.A., Sheedy I.P., Peyser P.A., Schwartz R.S., 2001 Longterm prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation., 104: 412–417.
• 15. Lomashvili K.A., Cobbs S., Hennigar R.A., Hardcastle K.I., O'Neill W.C., 2004 Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J. Am. Soc. Nephrol., 15: 1392–1401.
• 16. Luo G., Ducy P., McKee M.D., Pinero G.J., Loyer E., Behringer R.R., Karsenty G., 1997 Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature., 386: 78–81.
• 17. Matsushita M., Nishikimi N., Sakurai T., Nimura Y., 2000 Relationship between aortic calcification and atherosclerotic disease in patients with abdominal aortic aneurysm. Int Angiol., 3:276-9.
• 18. Nadra I., Mason J.C., Philippidis P., Florey O., Smythe C.D., McCarthy G.M., Landis R.C., Haskard D.O., 2005 Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification? Circ. Res., 96:1248–1256.
• 19. Neves K.R., Graciolli F.G., dos Reis L.M., Graciolli R.G., Neves C.L., Magalhaes AO, Custodio. MR, Batista DG, Jorgetti V, Moyses RM. 2007 Vascular calcification: contribution of parathyroid hormone in renal failure.Kidney Int., 71: 1262–1270.
• 20. Nicholls S.J., Tuzcu E,M., Wolski K., Sipahi I., Schoenhagen P., Crowe T., Kapadia S,R., Hazen S.L., Nissen S.E., 2007 Coronary artery calcification and changes in atheroma burden in response to established medical therapies. J. Am. Coll. Cardiol., 49: 263–270.
• 21. Niskanen L., Siitonen O., Suhonen M., Uusitupa M.I., 1994 Medial artery calcification predicts cardiovascular mortality in patients with NIDDM. Diabetes Care., 11:1252
• 22. Orita Y., Yamamoto H., Kohno N., Sugihara M., Honda H., Kawamata S., Mito S., Soe N.N., 2007 Yoshizumi M. Role of osteoprotegerin in arterial calcification: development of new animal model. Arterioscler. Thromb. Vasc. Biol., 27: 2058–2064.
• 23. Parhami F., Morrow A.D., Balucan J., Leitinger N., Watson A.D., Tintut Y., Berliner J.A., Demer L.L., 1997 Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation: a possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler. Thromb. Vasc. Biol.,17: 680–687.
• 24. Parhami F., Basseri B., Hwang J., Tintut Y., Demer L.L., 2002 Highdensity lipoprotein regulates calcification of vascular cells. Circ. Res., 91: 570–576.
• 25. Pawlikowski M., 1987 Mineralizacja organizmu człowieka żyjącego, (Mineralization of human living organism). Prace Mineral., 79:121.
• 26. Pawlikowski M., Ryskala Z., 1991 Charakterystyka mineralogiczno-chemiczna fosforanowej mineralizacji wybranych naczyń tętniczych człowieka. (Mineralogical-chemical characteristic of phosphate mineralization of human arteries). Roczniki Nauk Dyd, WSP w Krakowie Prace Fizjologiczne. : 81–104.
• 27. Pawlikowski M., 1991 Mineralizacja nowotworowa (Mineralization of cancer). In: Biomineralizacja i biomateriały. PWN, Warszawa, 84–92.
• 28. Pawlikowski M. 1993 Kryształy w organizmie człowieka, (Crystals of humanorganism). Secesja : 132 .
• 29. Pawlikowski M., 1995 Sekrety mineralizacji tkanek (Secrets of tissue mineralization). PAN Kraków : 97.
• 30. Pawlikowski M., 1999 Preliminary results of dissolution of substances mineralizing human arteries. Arch Mineralog., 52 :195.
• 31. Pawlikowski M., Pfitzner R, 1995 Zastosowanie metod mineralogicznychw badaniach tkanek człowieka. I. Sposoby badania mineralizacji. (Mineralogical methods useful for examination of human tissues). Przegl. Lekarski.;52:119–123.
• 32. Pawlikowski M., Pfitzner R. 1995 Zastosowanie metod mineralogicznych w badaniach tkanek człowieka. II. Mineralizacja struktur serca. (Mineralogical methods useful for examination of human tissues. Mineralization of heart structures). Przegl. Lekarski., :52:24–27.
• 33. Pawlikowski M., Pfitzner K., Skinner C., 1995. Cholesterol-mineral concentrations of the aneurysmatic wall. Acta Angiologica., :. 1–15.
• 34. Pawlikowski M., Pfitzner R., 1999 Mineralizacja serca i dużych naczyń, (Mineralization of heart and big blood vessels). Wyd IGSMiE PAN Kraków, :142
• 35. Pawlikowski M., 2003 Minerals in human blood vessels and their dissolution in vitro. In: Skinner HCW, Berger AW, editors. Geology and health. Oxford University Press., :155–158.
• 36. Pawlikowski M. 2011 Biomineralization of cancer tissues. 20th Int. Symp. Molecular and Physiological Aspects of Regulatory Processes of the Organism. Cracow, H Lach editors. Wyd Abaton Kraków.. :190–191.
• 37. Pawlikowski M., 2014 Osteoporosis as a source of tissue mineralization. Research on osteoporosis therapy and dissolution of arterial mineralization. Jour. Life Science.;8:610–625.
• 38. Pawlikowski M. 2017 Biomineralogy of angiogenesis. Arch. Clin. Biomed. Res., 1 :161–167.
• 39. Pawlikowski M., 2017a Centers of Human Tissue Biomineralization (Calcification). Cardiol. Cardiovasc. Med., 1 :252–262.
• 40. Price P.A., Faus S.A., Williamson M.K.. 2000; Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler. Thromb. Vasc. Biol., 20 :317–327.
• 41. Price P.A., June H.H., Buckley J.R., Williamson M.K., 2001. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler. Thromb. Vasc. Biol., 21: 1610–1616.
• 42. Price P.A,, Faus S.A., Williamson M.K., 2001 Bisphosphonates alendronate and ibandronate inhibit artery calcificationnn at doses comparable to those that inhibit bone resorption. Arterioscler. Thromb. Vasc. Biol., 21: 817–824.
• 43. Proudfoot D., Skepper J.N., Shanahan C.M., Weissberg P.L., 1998 Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. Arterioscler. Thromb. Vasc. Biol., 18: 379–388.
• 44. Qiao J.H., Xie P.Z., Fishbein M.C., Kreuzer J., Drake T.A., Demer L.L., Lusis A.J., 1994 Pathology of atheromatous lesions in inbred and genetically engineered mice: genetic determination of arterial calcification. Arterioscler. Thromb., 14 : 1480–1497.
• 45. Qiao J.H., Fishbein M.C., Demer L.L., Lusis A.J., 1995 Genetic determination of cartilaginous metaplasia in mouse aorta. Arterioscler. Thromb. Vasc. Biol., 15: 2265–2272.
• 46. Qiao J.H., Mertens R.B., Fishbein M.C., Geller S.A., 2003 Cartilaginous metaplasia in calcified diabetic peripheral vascular disease: morphologic evidence of enchondral ossification. Hum. Pathol., 34: 402–407.
• 47. Rajamannan N.M., Subramaniam M., Stock S.R., Stone N.J., Springett M., Ignatiev K.I., McConnell J.P., Singh R.J., Bonow R.O., Spelsberg T.C., 2005 Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart., 91: 806–810.
• 48. Reaven P.D, Sacks J., 2005. Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes. Diabetologia., 48: 379–385.
• 49. Rennenberg R..J., Schurgers L., Stehouwer C.,D.,A., 2010 Arterial calcifications. J. Cell. Mol. Med., 14: 2203–2210.
• 50. Reynolds J.L., Joannides A.J., Skepper J.N., McNair R., Schurgers L.J., Proudfoot D., Jahnen-Dechent W., Weissberg P.L., Shanahan C.M,. 2004; Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J. Am. Soc. Nephrol., 15: 2857–2867.
• 51. Sangiorgi G., Rumberger J.A., Severson A., Edwards W.D., Gregoire J., Fitzpatrick L.A., Schwartz R.S., 1998 Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J. Am. Coll. Cardiol., 31: 126–133.
• 52. Shanahan C.M., Proudfoot D., Farzaneh-Far A., Weissberg P.L., 1998 The role of Gla proteins in vascular calcification. Crit, Rev, Eukaryot, Gene, Expr., 8: 357–375.
• 53. Shao J.S, Cheng S.L., Charlton-Kachigian N., Loewy A.P., Towler D.A., 2003 Teriparatide (human parathyroid hormone (1–34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice. J. Biol .Chem., 278: 50195–50202.
• 54. Steitz S.A., Speer M.Y., McKee M.D., Liaw L., Almeida M., Yang H., Giachelli C.M., 2002; Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am. J. Pathol., 161: 2035– 2046.
• 55. Schmermund A., Achenbach S., Budde T., Buziashvili Y., Forster A., Friedrich G., Henein M., Kerkhoff G., Knollmann F., Kukharchuk V., Lahiri A., Leischik R., Moshage W., Schartl M., Siffert W., SteinhagenThiessen E., Sinitsyn V., Vogt A., Wiedeking B., Erbel R., 2006 Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial. Circulation., 113: 427–437.
• 56. Tanimura A., McGregor D.H., Anderson H.C., 1983 Matrix vesicles in atherosclerotic calcification. Proc. Soc. Exp. Biol. Med., 172: 173–177.
• 57. Tse J., Martin-McNaulty B., Halks-Miller M., Kauser K., DelVecchio V., Vergona R., Sullivan M.E, Rubanyi G.M., 1999 Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17 beta-estradiol. Atherosclerosis., 144: 303–313.
• 58. Wada T., McKee M.D., Steitz S., Giachelli C.M., 1999 Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ. Res., 84: 166–178.
• 59. Wang L., Jerosch-Herold M., Jacobs D.R. Jr, Shahar E., Detrano R., Folsom A.R., 2006 Coronary artery calcification and myocardial perfusion in asymptomatic adults: the MESA (Multi-Ethnic Study of Atherosclerosis). J. Am. Coll. Cardiol., 48: 1018–1026.
• 60. Weiss R.M., Ohashi M., Miller J.D., Young S.G., Heistad D.D., 2006Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation., 114: 2065–2069.
• 61. Vliegenthart R., Oudkerk M., Hofman A., Oei H.H., van Dijck W., van Rooij F.J., Witteman J.C., 2005 Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation., 112: 572–577.